<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Sumanbutler - Latest News</title>
<link href="https://news.newswirebiz.com/rss/sumanbutler/latest.xml"></link>
<updated>2026-07-20T21:21:59+00:00</updated>
<id>urn:uuid:29f3045a-8f9c-38b8-643d-e199490c34ca</id>
<entry>
<title>The medical device label contract manufacturing market is projected to reach USD 509 million in 2030, predicts Roots Analysis</title>
<link href="https://news.newswirebiz.com/@sumanbutler/the-medical-device-label-contract-manufacturing-market-is-projected-to-reach-usd-509-million-in-2030-predicts-roots-analysis-pj3nar6j78xq"></link>
<id>urn:uuid:99217a86-bce5-bae5-de63-03397a7fc5ca</id>
<summary type="html"><![CDATA[Outsourcing the manufacturing of labels is a popular trend among medical device developers, enabling such companies to leverage the advanced capabilities of CMOs, while focusing on the core aspects of product development]]></summary>
<updated>2021-09-01T10:31:15+00:00</updated>
</entry>
<entry>
<title>The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis</title>
<link href="https://news.newswirebiz.com/@sumanbutler/the-subcutaneous-biologic-drugs-and-affiliated-technologies-market-is-projected-to-be-worth-over-usd-180-billion-by-2030-predicts-roots-analysis-b68qermk78dj"></link>
<id>urn:uuid:67f6e3b3-0212-a900-f966-169b477383ca</id>
<summary type="html"><![CDATA[Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals]]></summary>
<updated>2021-09-01T06:44:17+00:00</updated>
</entry>
<entry>
<title>Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030</title>
<link href="https://news.newswirebiz.com/@sumanbutler/growing-at-an-annualized-rate-of-over-165-the-cell-therapy-manufacturing-market-is-estimated-to-reach-close-to-usd-11-billion-by-2030-p43kxrp4n8bj"></link>
<id>urn:uuid:81eac649-2a68-c119-5cbc-8df51fde3227</id>
<summary type="html"><![CDATA[The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity]]></summary>
<updated>2021-08-27T10:08:26+00:00</updated>
</entry>
<entry>
<title>Global Psychedelic Therapeutics Market by Roots Analysis</title>
<link href="https://news.newswirebiz.com/@sumanbutler/global-psychedelic-therapeutics-market-by-roots-analysis-6p3w7qrem35y"></link>
<id>urn:uuid:4758e521-3341-450b-a594-045cbe1062bb</id>
<summary type="html"><![CDATA[A growing body of evidence suggests that using psychedelics, such as psilocybin and LSD, in combination with psychotherapy, can treat the symptoms of several mental health conditions, including depression and substance use disorders]]></summary>
<updated>2021-08-20T11:45:29+00:00</updated>
</entry>
</feed>